Christopher Robert Clark

Christopher Clark practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Christopher Clark's NPI, 1346583077, was assigned on April 1, 2013. Christopher Clark holds Michigan license 4301103787.

Christopher Clark's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Christopher Clark's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. The medical group on file is Henry Ford Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Clark practices. Vendor and product names are available with a free account.

Emergency medicine is Christopher Clark's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Christopher Clark is licensed in Michigan.

CMS data shows 141 Medicare services from Christopher Clark across 5 procedure codes in 2024, for 119 Medicare patients. Medicare paid $15,405 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Christopher Clark in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Clark's median patient age at 68, with 49% women.

In 2024, Christopher Clark wrote 33 Medicare Part D claims for 18 patients. 97% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $98 in total drug cost. In 2017, CMS named 15 claims across 1 drug.

Christopher Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Christopher Clark from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $65.